PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Discontinued)

PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation supports small businesses in conducting research and development of innovative technologies that align with the missions of NIH and CDC, including areas related to mental health where clinical trials are not proposed.

PHS 2024-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA). The SBIR Omnibus Solicitation invites small businesses to submit investigator-initiated research proposals across a broad spectrum of health-related topics, including those relevant to oncology, aligning with the missions of NIH, CDC, and FDA.

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) is sponsored by National Institutes of Health (NIH), Centers for Disease Control (CDC). Similar to the 'Clinical Trial Not Allowed' parent announcement, this opportunity supports U. S. small businesses in research and development with commercialization potential, specifically for projects requiring clinical trials.

PHS 2024-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). PHS 2024-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA…

PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This NIH and CDC Omnibus Solicitation invites eligible U. S. small businesses to submit SBIR grant applications for research and development projects that do not involve a clinical trial.

PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by Department of Health and Human Services (HHS) (National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA)). This omnibus solicitation invites Small Business Innovation Research (SBIR) grant applications from small business concerns for research and development projects across a broad range of health-related areas.

PHS 2024-2 Omnibus Solicitations of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This solicitation invites small business concerns to submit Small Business Innovation Research (SBIR) grant applications that propose a clinical trial, focusing on scientific research and development with strong commercial potential in health and biomedical fields.

PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA). This omnibus solicitation supports research and development projects in biomedical informatics and data science, including AI techniques for characterizing and minimizing errors in health-related datasets, novel platforms for integrating patient data, and technological approache…

PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) is sponsored by National Institutes of Health (NIH). This program provides funding for small businesses to engage in early-stage research and development in areas relevant to the missions of NIH and CDC. It aims to stimulate technological innovation and increase private sector commercialization of innovations. Small businesses are eligible to apply to many of NIH's standard programs.